Oppenheimer has upgraded Microsoft to Outperform with a $600 price target, citing underappreciated growth potential in AI and ...

The sustaining growth of the company’s AI revenue and cloud platform Azure are not fully priced into the stock, Oppenheimer ...

Abbott Laboratories (NYSE:ABT) is a healthcare company that discovers, develops, manufactures, and sells a range of ...

Oppenheimer upgraded Microsoft's (NASDAQ:MSFT) rating to Outperform from Perform and set a $600 price target, spotlighting the U.S. tech giant's AI opportunity. Shares of Microsoft rose about 1% ...

Microsoft Corp. was upgraded at Oppenheimer on Wednesday, adding to a growing consensus on Wall Street that the software ...

Fittingly, the final episode of The Handmaid's Tale was an easter egg in and of itself. It's the first time in the show's eight-year run that the series has used the title of Margaret Atwood's novel ...

On this week’s “More To The Story,” Daniel Holz from the Bulletin of the Atomic Scientists discusses why the hands of the ...

People and governments are generally living in the past and haven't embraced that extreme weather is now the norm ...

Experts say climate change is making extreme weather events more frequent and severe, but that our attitudes and actions ...

The Yankees’ braintrust nodded knowingly when George Lombard Jr. displayed a complete package well beyond his two decades on ...

Wix.com Ltd. (NASDAQ:WIX) is one of the Top 10 Stocks to Buy According to Lakehouse Capital. Oppenheimer reiterated an ...

Pulse-pounding epic thriller Oppenheimer is due to hit Netflix within the week, so mark your calendars and get all the ...